Incidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE)
dc.contributor.author | von Moos, R | |
dc.contributor.author | Hawle, H | |
dc.contributor.author | Hayoz, S | |
dc.contributor.author | Cathomas, R | |
dc.contributor.author | Muller, A | |
dc.contributor.author | Schmid, S | |
dc.contributor.author | Pagani, O | |
dc.contributor.author | Wehrhahn, T | |
dc.contributor.author | Rauch, D | |
dc.contributor.author | Anchisi, S | |
dc.contributor.author | Hermanns, T | |
dc.contributor.author | Fehr, M | |
dc.contributor.author | Stoll, S | |
dc.contributor.author | Butzberger, P | |
dc.contributor.author | Zweifel, M | |
dc.contributor.author | Huber, U | |
dc.contributor.author | Fuhrer, AC | |
dc.contributor.author | Schar, C | |
dc.contributor.author | Gillessen, Silke | |
dc.contributor.author | Templeton, AJ | |
dc.date.accessioned | 2019-04-29T09:48:53Z | |
dc.date.available | 2019-04-29T09:48:53Z | |
dc.date.issued | 2018 | en |
dc.identifier.citation | von Moos R, Hawle H, Hayoz S, Cathomas R, M�ller A, Schmid S, et al. 1703P Incidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE). Annals of Oncology. 2018;29(suppl_8). | en |
dc.identifier.pmid | No PMID | en |
dc.identifier.doi | 10.1093/annonc/mdy300.020 | en |
dc.identifier.uri | http://hdl.handle.net/10541/621734 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1093/annonc/mdy300.020 | en |
dc.title | Incidence of hypocalcemia in a non-inferiority phase III trial assessing prevention of symptomatic skeletal events (SSE) with denosumab (DN) administered every 4 weeks (q4w) versus every 12 weeks (q12w): SAKK 96/12 (REDUSE) | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Department of Oncology/Hematology, Kantonsspital Graub�nden, Chur, Switzerland | en |
dc.identifier.journal | Annals of Oncology | en |
dc.description.note | en] | |
refterms.dateFOA | 2020-04-20T12:33:33Z |